Sort
130,381 grants matching “hiv”
Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS)
$4,100,375Anjali Sharma · Albert Einstein College Of Medicine · U01 · FY2025 · HL
Penn Center for AIDS Research
$4,100,153Ronald G Collman · University Of Pennsylvania · P30 · FY2020 · AI
PROVISION OF MEDICAL MALE CIRCUMCISION (MMC) FOR HIV PREVENTION IN KWAZULU NATAL
$4,100,000Nikki Soboil · Sactwu Aids Project · U2G · FY2013 · GH
IMPROVEMENT OF INTEGRATED HIV CLINICAL-BASED SERVICES
$4,100,000Jean William Pape · Gheskio Center · U2G · FY2011 · GH
Defense-in-depth against mucosal HIV clade C invasion
$4,095,518Ruth Margrit Ruprecht · Texas Biomedical Research Institute · P01 · FY2016 · AI
Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS)
$4,093,644Anjali Sharma · Albert Einstein College Of Medicine · U01 · FY2023 · HL
MBRS-SCORE Program at UPR-Medical Sciences Campus
$4,092,161Walter I Silva · University Of Puerto Rico Med Sciences · S06 · FY2007 · GM
University of North Carolina Global HIV Prevention and Treatment Clinical Trials Unit
$4,091,472Joseph J. Eron · Univ Of North Carolina Chapel Hill · UM1 · FY2023 · AI
Terry Beirn CPCRA Clinical Trials Unit
$4,090,330Virginia Kan · George Washington University · UM1 · FY2018 · AI
PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS
$4,087,297David Kern · Washington State Department Of Health · U62 · FY2014 · PS
University of Pittsburgh MACS/WIHS CCS
$4,084,069Charles R Rinaldo · University Of Pittsburgh At Pittsburgh · U01 · FY2023 · HL
UZ-UCSF Clinical Trials Unit
$4,083,626Zvavahera Mike Chirenje · University Of California, San Francisco · UM1 · FY2012 · AI
PHASE 1 CLINICAL TRIALS UNITS FOR THERAPEUTICS AGAINST INFECTIOUS DISEASES: EVALUATION OF THERAPEUTICS FOR NEISSERIA GONORRHOEAE
$4,083,461David Shumway · Dynport Vaccine Company, Llc · N01 · FY2017 · AI
Northwestern CORE Clinical Research Site: Trans-omics for HIV/AIDS Research
$4,083,010Steven M Wolinsky · Northwestern University At Chicago · U01 · FY2021 · HL
Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) - Baltimore/Wash DC Center
$4,081,180Joseph B. Margolick · Johns Hopkins University · U01 · FY2022 · HL
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)
$4,078,460James Dennis Neaton · University Of Minnesota · U01 · FY2008 · AI
Retroviral Mediated Gene Transfer Into Primate Hematopoietic Cells
$4,078,100Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIC · FY2013 · HL
SHIV Env-antibody coevolution as a molecular guide to HIV-1 V3 glycan targeted vaccine design
$4,076,804George M Shaw · University Of Pennsylvania · P01 · FY2024 · AI
Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) - Baltimore/Wash DC Center
$4,074,684Joseph B. Margolick · Johns Hopkins University · U01 · FY2024 · HL
Global innate immune responses to HIV-1 infection
$4,074,664John A T Young · Salk Institute For Biological Studies · P01 · FY2011 · AI
ENHANCED COMPREHENSIVE HIV PREVENTION & IMPLEMENTATION-AREAS AFFECTED BY HIV/AIDS
$4,073,411Edmund R. Dunn · New York City Health/Mental Hygiene · U65 · FY2011 · PS
Defects in Immunoregulatory Cell Receptors in Patients with LeukemiaLymphoma
$4,070,979Thomas A Waldmann · Clinical Sciences · Z01 · FY2007 · CA
FOA: PS04-012, HIV PREVENTION PROJECTS
$4,068,878Andre W. Rawls · Illinois State Dept Of Public Health · U62 · FY2007 · PS
Targeted Modification of Host and Proviral DNA to Treat Latent HIV Infection
$4,068,789Keith R Jerome · Fred Hutchinson Cancer Research Center · U19 · FY2014 · AI
Johns Hopkins Excellence in Pathogenesis and Immunity Center for SARS-CoV-2 (JH-EPICS)
$4,067,207Sabra L Klein · Johns Hopkins University · U54 · FY2020 · CA